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The successes of genome-wide association (GWA) studies have mainly come from studies performed in
populations of European descent. Since complex traits are characterized by marked genetic heterogeneity,
the ﬁndings so far may provide an incomplete picture of the genetic architecture of complex traits.
However, the recent GWA studies performed on East Asian populations now allow us to globally assess
the heterogeneity of association signals between populations of European ancestry and East Asians, and
the possible obstacles for multi-ethnic GWA studies. We focused on four different traits that represent a
broad range of complex phenotypes, which have been studied in both Europeans and East Asians: type 2
diabetes, systemic lupus erythematosus, ulcerative colitis and height. For each trait, we observed that
most of the risk loci identiﬁed in East Asians were shared with Europeans. However, we also observed
that a signiﬁcant part of the association signals at these shared loci seems to be independent between popu-
lations. This suggests that disease aetiology is common between populations, but that risk variants are often
population speciﬁc. These variants could be truly population speciﬁc and result from natural selection, gen-
etic drift and recent mutations, or they could be spurious, caused by the limitations of the method of analysis
employed in the GWA studies. We therefore propose a three-stage framework for multi-ethnic GWA analyses,
starting with the commonly used single-nucleotide polymorphism-based analysis, and followed by a gene-
based approach and a pathway-based analysis, which will take into account the heterogeneity of association
between populations at different levels.
INTRODUCTION
Complex traits refer to the phenotypes that are classically
believed to result from the interplay of multiple genetic var-
iants and environmental factors. Genome-wide association
(GWA) studies, in which phenotypes are compared for differ-
ences in genetic variation, have revolutionized the search for
genetic risk variants underlying these complex traits. During
the past few years, GWA studies have identiﬁed robust asso-
ciations between .3000 single-nucleotide polymorphisms
(SNPs) and .700 complex human traits (1). The majority
of the GWA studies have been centred on populations of
European descent (henceforth referred to as ‘Europeans’).
Because complex traits are caused by an interplay of genetic
variation and environmental factors, their genetic basis prob-
ably reﬂects the evolution of the human genome and human
populations. Genomic surveys have already revealed a sub-
stantial divergence of genetic variation across populations in
terms of allele frequency, linkage disequilibrium (LD) and
haplotype structure (2–4). These inter-population differences
in genetic architecture reﬂect multiple factors such as
genetic drift, recent mutations, environmental factors and
other evolutionary forces (5). Consequently, complex traits
are anticipated to be genetically heterogeneous (6,7). This
inter-population heterogeneity of complex traits raises the
question as to how far GWA ﬁndings can be translated
across different ethnic groups. For targeted disease therapy
and genetic risk prediction, knowing how much genetic risk
loci can be translated between different ethnicities is vital; het-
erogeneity of genetic risk between populations could consider-
ably limit the applicability of such therapies and risk models
across populations. For cross-ethnicity mapping, on the other
hand, inter-population heterogeneity can be advantageous;
cross-ethnicity mapping combines the association signals
across multiple different ethnicities, increasing the power for
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remains unclear to what extent complex traits are heteroge-
neous between populations; a study by Water et al., for
example, assessed the association of 19 loci with type 2 dia-
betes (T2D) in ﬁve ethnic populations and observed consistent
association for most of the association signals (8). However, a
recent study by Sim et al. (9) concluded that there is consider-
able locus and allelic heterogeneity in T2D association
between populations. Sim et al. performed genome-wide
scans for T2D risk loci on three Asian populations and com-
pared the association signals to those in Europeans. This
example suggests that the assessment of transferability of
risk variants across populations needs to be based on unbiased
GWA ﬁndings from each population. Such unbiased assess-
ment is currently impossible for several reasons: GWA
studies employ tag-SNPs that are more likely to be proxies
of the causal variants than true causal variants; hence, any per-
ceived heterogeneity could be due to heterogeneity of the
tag-SNP rather than of the true causal variant; GWA platforms
are designed for optimal use in European populations and are
hence less sensitive in non-European populations; for most
complex traits, results from European studies have already
been published, colouring the interpretation of results in
non-European populations; and ﬁnally, there are few non-
European GWA studies and they are generally underpowered.
Nonetheless, the recent progress of GWA studies in East
Asians allows us to make a preliminary empirical comparison
of the association signals between Europeans and East Asians
as a proxy of the genetic heterogeneity of complex traits
between populations, and provides an opportunity to explore
the implications of the heterogeneity of association signals
in multi-ethnic GWA studies.
Recent advances in GWA studies in East Asians
Since 2009, the focus of genetic studies in East Asians has
clearly switched from the replication of small sets of risk
variants reported in Europeans to genome-wide analyses to
discover new risk loci. The total number of GWA studies
in East Asians, including Chinese, Japanese and Korean
populations, has increased greatly in the last 30 months
from 5 at the beginning of 2009 to 84 by May 2011 (1).
Although many of the hypothesis-free GWA studies in
East Asians resemble those in the early stages of the
GWA era in Europeans, with relatively small sample
sizes, these studies have already successfully reported risk
loci not previously detected in Europeans, thereby yielding
new insights into the aetiology of complex traits (10). In
addition, the GWA studies in East Asians may provide
unique information, especially for those complex diseases
that have a much higher prevalence in East Asians than
in Europeans. This is, for example, the case with hepatocel-
lular carcinoma, the incidence of which is ,2 in 100 000
males in the Western world but 40–60 in 100 000 males
in Africa and East Asia (11,12). Three GWA studies on
hepatocellular carcinoma in East Asians report a total of
six risk loci, whereas no such study has so far been per-
formed in Europeans (13–15). GWA studies that include
non-European populations thus hold the promise of being
able to provide a broader spectrum of complex trait loci
and a higher resolution for exploring the genetic architecture
of such traits.
Heterogeneity of association signals between Europeans
and East Asians
To gain maximal power from multi-ethnic GWA studies, it is
important to know the extent of heterogeneity of association
signals between populations and the implications for genetic
studies. Here, we conﬁned ourselves to four different
complex traits or diseases that have been studied in both
Europeans and East Asians, which represent a broad range
of complex phenotypes: (i) a metabolic disease: T2D, with a
similar prevalence in both populations (Europeans 5.7–7.8%
and East Asians 5.5–11.7%); (ii) two inﬂammatory diseases:
systemic lupus erythematosus (SLE), with a higher prevalence
in East Asians (161 in 100 000) than in Europeans (91 in 100
000), and ulcerative colitis (UC), with a higher prevalence in
Europeans (100 in 100 000) than in East Asians (6–16.1 in
100 000) and (iii) an anthropomorphic trait, height, with an
average difference of 7 cM between East Asians and
Europeans. For each trait we derived all the reported SNPs
associated to the traits from the Catalogue of Published
Genome-Wide Association Studies (GWAS Catalogue, avail-
able at: www.genome.gov/gwastudies; accessed on 15 May
2011) (1). The sample sizes of GWA studies in East Asians
are generally much smaller than those in Europeans. This rela-
tive underpowering of GWA studies in East Asians has
resulted in a lower number of susceptibility loci detected in
East Asians. We therefore based further analysis exclusively
on associations reported in East Asians at a genome-wide
signiﬁcant level (P , 5 × 10
28). We ﬁrst clustered all
reported SNPs into LD blocks (r
2. 0.8) and assigned an
index SNP, the most associated SNP, to each LD block.
Then we took a window size of 1 Mb around the index
SNPs (0.5 Mb on each side) and clustered all reported SNPs
into genomic loci. In this manner, we selected 43 risk loci
(47 index SNPs): 13 for T2D, 19 for SLE, 3 for UC and 8
for height (Table 1). For these risk loci, we assessed
whether they were associated in Europeans, where the power
of GWA studies should be much greater. We extracted all
SNPs reported in European studies from the GWAS Catalogue
and then manually checked the supplementary data of each of
the papers to include, where available, all the SNPs reported at
1 × 10
25 in the original papers. We considered the association
loci to be either: (i) speciﬁc to East Asians, when the power of
the study in Europeans was .80% but no association was
reported in Europeans at P , 1 × 10
25 at this locus (Supple-
mentary Material, Notes); or (ii) shared with Europeans, when
either the same SNP was associated at P , 1 × 10
25 or differ-
ent SNPs within the same region were associated at P , 5 ×
10
28 in Europeans. For the shared loci, we further assessed
whether the association was: (i) to the same SNPs, (ii) to
highly linked SNPs or (iii) to independent SNPs (Table 1
and Fig. 1).
Population-speciﬁc loci. Considering the risk loci detected in
East Asians and the power calculations for these loci in the
European studies (Supplementary Material, Notes), we
observed that there were only a few loci which show
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example, the population-speciﬁc T2D risk loci, UBE2E2 and
C2CD4A-C2CD4B, were reported by two relatively small
East Asian GWA studies for T2D, while these loci did not
reach genome-wide signiﬁcance in European studies
performed on cohorts 10 times larger (10,16,17). A possible
explanation for the apparent population speciﬁcity of associ-
ation signals can be a very low minor allele frequency
(MAF) of a risk SNP, thereby reducing the power for detecting
the signal (Fig. 2). For example, the most associated SNP in
the UBE2E2 locus, rs6780569, has a relatively low allele fre-
quency in HapMap CEU panel (MAF ¼ 0.093) compared with
CHB + JPT panel (MAF ¼ 0.222) (Fig. 2). However, the
association in East Asians was clearly genome-wide signiﬁ-
cant (P ¼ 1.04 × 10
29), whereas in Europeans it was com-
pletely absent (P ¼ 0.976) (10), although the European study
had sufﬁcient power to detect the association signal (Supple-
mentary Material, Table S1). This renders a false-negative
signal in Europeans unlikely. For the C2CD4A-C2CD4B
locus, the most associated SNP is equally common in both
populations (Fig. 2), so the power for detecting the association
signal is high in the European population (Supplementary
Material, Table S1). The association to SNP rs7172432
could be replicated in Europeans at P ¼ 6.36 × 10
25 (10),
which does not pass our deﬁned threshold (P , 1 × 10
25).
This suggests that we need to be cautious in deﬁning risk
loci as shared or non-shared between populations. Seemingly
population-speciﬁc risk loci may well be spurious due to the
threshold for signiﬁcance and the power of the study. Thus,
population-speciﬁc loci need further replication with larger
sample sizes. The presence of population-speciﬁc loci,
whether spurious or true, is however something that should
be taken into account when performing multi-ethnic GWA
studies.
Shared risk loci between East Asians and Europeans. Out of
43 loci associated in East Asians, we observed that 32%
(6 of 19 SLE loci) to 100% (8 of 8 height loci) of the loci
per trait were shared with Europeans (Table 1). For these
shared loci, we further assessed whether the same or different
SNPs were associated in each population and we compared the
LD between the European- and East Asian-associated SNPs.
Association signal to the same SNP. In our analysis, we
observed several incidences in which an association signal to
the same SNP was found in East Asians and Europeans
(Table 1 and Fig. 1). One example of these is the T2D risk
variant rs7903146 at the TCF7L2 locus (10q25.2). This
variant has not only been reported in Europeans and East
Asians, but also in African Americans, Latinos and Hawaiians
(8). The number of risk SNPs shared between populations is,
however, not representative of the actual overlap in genetic
background between the populations: report of an association
to the same SNP in a region depends largely on the platform
Figure 1. The linkagedisequilibrium(LD) between European-associated SNPs
and East Asian-associated SNPs at the shared susceptibility loci. The suscepti-
bility loci shared between the Europeans and East Asians are named after the
gene closest to the index SNP in each locus. The colours of the loci refer to
the different traits: blue for type 2 diabetes (T2D), brown for SLE, green for
UC and black for height. The loci in bold indicate the loci with the same
index SNPs reported in both populations. The LD is the pairwise r
2 between
the European-associated SNP and the East Asian-associated SNP at each
locus. The x-axis represents the r
2 in the HapMap CEU reference panel (Utah
residents with European ancestry) and the y-axis represents the r
2 in HapMap
CHB + JPT reference panel (Han Chinese from Beijing and Japanese from
Tokyo). The light pink region indicates the loci with linked signals (r
2. 0.8)
in any referencepanel. The light blue regionindicates the lociwith independent
signals (r
2,0.2 in both reference panels or distance .500 kb).
Table 1. The association of East Asian-associated loci in individuals of
European ancestry
T2D SLE UC Height
Number of unique risk
loci detected in
East Asians
(P , 5 × 10
28)
13 (15 SNPs) 19 (19 SNPs) 3 (3 SNPs) 8 (10 SNPs)
Number of loci
speciﬁc to East
Asians
a
5 1 (8) 1 0
Number of loci shared
in Europeans
b
862 8
Same SNPs 3 1 2 1
Highly linked SNPs 3 1 0 2
Independent SNPs 2 3 0 1
Weakly linked
SNPs
010 4
T2D, type 2 diabetes; SLE, systemic lupus erythematosus; UC, ulcerative
colitis.
aThe number of loci speciﬁc to East Asians refers to the loci that are
signiﬁcantly associated in East Asians at a genome-wide signiﬁcance level
P-value ,5 × 10
28, but for which no association was detected in Europeans at
a signiﬁcance level P-value , 1 × 10
25 with at least 80% power. The number
in brackets refers to the number of spurious East Asian-speciﬁc loci where
European studies had ,80% power to detect the association signals.
bThe LD, in terms of r
2, between the SNPs was assessed based on HapMap
reference panels. For individuals of European ancestry, we used HapMap CEU
reference panel (Utah residents with European ancestry). For the East Asian
population, we used HapMap CHB + JPT reference panel (Han Chinese from
Beijing and Japanese from Tokyo). The association with highly linked SNPs
refers to the loci where r
2 is .0.8 in any population. The association with
independent SNPs refers to the loci where r
2 is ,0.2 in both populations. The
weakly linked SNPs are the remaining loci with r
2 between 0.2 and 0.8.
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Furthermore, slight differences in allele frequency between
populations can inﬂuence the P-value at a certain SNP,
leading authors to report their association within a single
shared locus to a different SNP.
Highly linked SNPs at the same locus. To identify shared risk
signals while trying to avoid the platform-, power- and publi-
cation biases, we considered a risk locus shared if the asso-
ciated SNPs were in high LD (r
2. 0.8) in any population. If
multiple index SNPs at the same locus were reported, we
chose the closest pair of the European- and East Asian-
associated SNPs in terms of r
2 and genomic distance. At
many of the risk loci, the association signals in Europeans
are in a near-perfect LD with the original East Asian associ-
ation signal, suggesting that these signals originate from the
same risk variant. For example, multiple variants in the
intron of the CDKAL1 have consistently been reported as
risk factors for T2D in individuals of European (rs7754840)
and East Asian descent (rs4712523). Even though different
SNPs show a genome-wide signal in each population, these
SNPs are in LD with each other (r
2. 0.98 in both populations)
and seem to point to a single T2D causal variant.
Independent SNPs at the same locus. Although the risk loci
can be shared between populations, it is still possible that
risk variants within these loci are population speciﬁc. If the
r
2 between the association signals was ,0.2 in both popula-
tions, or if the distance between the signals was .500 kb,
we considered the signal to be independent (Table 1 and
Fig. 1). We observed several such loci with multiple risk var-
iants, including the T2D risk locus KCNQ1. The association of
KCNQ1 was primarily reported in East Asians, with three
independent SNPs (rs2237892, rs2237895 and rs2237897) at
the intron of the KCNQ1 gene. The strongest association
was detected at rs223792 (P ¼ 1.7 × 10
242)( 18). Later, in
Europeans, the association was reported at another intron
SNP rs231362 (17). This SNP is, however, independent of
any of the SNPs detected in East Asians (all r
2, 0.02 in
any populations). This example suggests that multiple and
population-speciﬁc risk variants can exist at one gene. These
independent risk variants within the shared loci could point
to population-speciﬁc independent causal variants within a
region that is functionally important for disease pathogenesis.
A recent haplotype analysis on the KCNQ1 region in Indian
and European populations suggested that T2D risk associated
with KCNQ1 SNPs may be derived from the ‘G’ allele of
rs231362 and the ‘C’ allele of rs2237895 and is likely to be
mediated by b cell function (19). However, seemingly inde-
pendent risk variants could also arise as a result of allele fre-
quency differences. The top East Asian-associated KCNQ1
SNP rs2237892 is common (MAF ¼ 0.38) in the HapMap
CHB + JPT reference panel (Han Chinese from Beijing and
Japanese from Tokyo) but has a relatively low frequency
(MAF ¼ 0.08) in the HapMap CEU reference panel (Utah
residents with European ancestry). In contrast, the European-
associated SNP rs231362 is less common in East Asians than
Europeans (MAF ¼ 0.167 in HapMap CHB + JPT and
MAF ¼ 0.49 in HapMap CEU) (Fig. 2). The same was
observed in the height-associated locus IGF1:t h e
European-associated SNP rs7971536 is frequent in HapMap
CEU (MAF ¼ 0.475) but rare in HapMap CHB + JPT
(MAF ¼ 0.011). In contrast, the East Asian-associated SNP
rs5742692 (425.8 kb distance from rs7971536) has a frequency
of 0.222 in the HapMap CHB + JPT, but a frequency of 0.017
in the CEU panel (Fig. 2). This observed allelic heterogeneity
likely results from natural selection or genetic drift (5,20)a n d
could result in seemingly population-speciﬁc associations
(Supplementary Material, Table S2). Most other independent
SNPs in shared risk loci are common in both populations but
the association is apparently population speciﬁc.
CONCLUDING REMARKS
We have explained how the genetic basis of complex traits can
be heterogeneous between populations based on GWA ﬁnd-
ings. At present we can only compare a handful of associated
loci for a few traits reported in Europeans and East Asians,
which limits how representative our analysis can be
Figure 2. Comparison of the minor allele frequencies of the population-
speciﬁc SNPs. Each dot represents the population-speciﬁcally associated
SNPs from each East Asian speciﬁc locus or shared risk locus: the red
squares indicate East Asian-associated SNPs from the East Asian-speciﬁc
loci; the red circles indicate the East Asian-associated SNPs from the shared
loci; and the diamonds show the European-associated SNPs from the shared
loci. The SNP IDs, their associated traits and the gene closest to the signal
are indicated. The colours refer to the different traits: blue for type 2 diabetes
(T2D), brown for SLE, green for UC and black for height. The x-axis represents
the MAFs of the SNPs in the HapMap CEU reference panel (Utah residents with
European ancestry); the y-axis represents the MAFs of the SNPs in the HapMap
CHB + JPT reference panel (Han Chinese from Beijing and Japanese from
Tokyo). The dashed grey lines indicate the MAF ¼ 0.05, which is the cut-off
between common SNPs and rare SNPs. The SNPs with different minor allele
are highlighted by asterisk. The SNPs highlighted by open boxes are example
cases for a population-speciﬁc locus (blue box) and for independent SNPs at
shared loci (orange box). The SNPs in bold refer to the population-speciﬁc
SNPs for which studies in Europeans had .80% power to detect the association
signal. Other SNPs refer to spurious population-speciﬁc SNPs for which studies
in Europeans had ,80% power to detect the association signal.
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and hence the comparison with European studies may be
affected by power issues. Secondly, Europeans and East
Asians are in fact genetically similar, whereas more major
genetic differences are expected to be found between
African and non-African populations (21). Unfortunately, the
number of GWA studies performed in individuals of African
descent is still too limited to enable comparative studies.
In our analysis using East Asian reported loci as a starting
point, we observed considerable heterogeneity of association
signals between East Asians and Europeans. Most risk loci
seem to be shared, whereas the risk signals often appeared
to be population speciﬁc.
Our study demonstrates the challenge in assessing the trans-
ferability of risk variants between different ethnic populations
solely based on the GWA ﬁndings. There is no doubt about the
existence of the population-speciﬁc risk variants, as illustrated
by examples like the population-speciﬁc association of MYH9
with end-stage renal disease in African Americans (22,23) and
the population-speciﬁc association of NOD2 with Crohn’s
disease in Europeans (24,25). However, the assessment of
genetic heterogeneity solely based on GWA ﬁndings is
affected by the limitations of GWA studies. First, the
genetic variants identiﬁed through GWA studies have small
or moderate risk effects and explain only a small part of the
heritability of most complex traits. Thus, when comparing
the results of GWA studies between different populations,
we compare only a small fraction of the total genetic risk
present in each population, leading to many seemingly
population-speciﬁc signals. This would lead us to overestimate
the genetic heterogeneity across populations. Secondly, GWA
studies are inherently ill suited for detecting population-
speciﬁc risk variants because the risk variants targeted by
such studies are often common variants that are believed to
be of ancient origin and shared among different populations.
Risk can however also be conveyed by rare variants, which
usually have a recent origin. Rare risk variants are more
likely to be population-speciﬁc and could possibly carry a
greater risk effect (Fig. 3). The fact that the current GWA
study design does not identify rare risk variants explains part
of the missing heritability of complex traits and probably
leads us to underestimate the genetic heterogeneity across
populations. The recent advances in high-throughput sequen-
cing technology have greatly accelerated the discovery of
rare variants and have led to the development of custom-made
arrays that speciﬁcally include rare variants (26,27).
This advance in the discovery of rare variants can greatly
aid in detecting the risk contributed by rare variants. Although
these rare variants are individually difﬁcult to detect, they can
collectively make a substantial contribution to the genetic risk
underlying complex traits. Thirdly, the risk variants reported
by GWA studies are just proxies of the actual causal variants;
ﬁnding a population-speciﬁc risk variant does not necessarily
mean that the causal variant is also population speciﬁc. The
inter-population difference in LD between tag-SNPs and
causal variants, and inter-population differences in allele fre-
quency, can lead to association signals at different SNPs in
different populations. This limitation can result in an overesti-
mation of genetic heterogeneity between populations. As the
causal variants remain undetermined, the inter-ethnic hetero-
geneity of the tag-SNPs from GWA studies can interfere sig-
niﬁcantly with multi-ethnic genome-wide meta-analyses.
Although comparing GWA signals from different popula-
tions has limited value for assessing the exact extent of the
heterogeneity of complex traits across populations, it clearly
shows the immense implications of this heterogeneity for
GWA studies on multi-ethnic samples. Such studies have
several potential applications. In population genetics, an im-
portant application of multi-ethnic studies is the mapping of
ancestry in modern populations consisting of an admixture
of populations with geographically divergent ancestry. Such
mapping can, for example, be performed in African Americans
and Latinos, revealing a mosaic genome of distinct ancestry.
Admixture mapping can provide unforeseen power and reso-
lution in genetic analysis (28–31). In complex trait genetics,
the two most well-known applications of multi-ethnic GWA
studies are meta-analyses, combining the association signals
in different populations to increase the power for detecting
new risk loci, and ﬁne-mapping, using the divergent
genomic structure between different populations for ﬁnding
the causal genetic variant in a shared risk locus. If the goal
of a multi-ethnic GWA study is a meta-analysis to increase
the power to detect new risk loci, it is important that the popu-
lations are genetically close enough to assume that the causal
Figure 3. The comparison of MAFs between the population-shared SNPs and the population-speciﬁc SNPs.
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Through the evolutionof the humangenome, complex traitsare characterized bymarkedheterogeneity across populations, as can be
seen in the comparison of association signals across populations. The overall genetic basis and pathological mechanisms underlying
complex traits may be identical between different ethnic populations, but the variants representing this risk can be population speciﬁc.
To cope with the genetic heterogeneity of complex traits and to gain maximal power in multi-ethnic GWA studies, we
propose to incorporate gene- and pathway-based association analyses into the analysis framework for multi-ethnic GWA
studies (Fig. 4). Unlike the traditional SNP-based approach, the gene- and pathway-based approaches can take into
account both the consistency and inconsistency of association between populations at different levels.
SNP-based approach
The meta-analysis ona single SNP levelis currentlythe standardapproachforcombiningassociationsignals frommultiple GWA
studies.Theprocedureincludesgenotypeimputationbasedontheappropriatereferencepanel,testingtheassociationperimputedand
directlygenotypedSNPineachGWAstudy,performingameta-analysistocombinetheassociationsignalsfromdifferentstudies,and
testing for between-study heterogeneity and correcting for this (32). Applying this meta-analysis method to multi-ethnic association
studies has the disadvantage that it is targeted at the shared and more common risk variants among populations, whereas signals of
population-speciﬁcriskvariantswillbediluted.ThisisduetothefactthatimputationoftheGWAdataforthedifferentethnicsamples
needstobeperformedwithareferencepanelfromthesameethnicorigin.MostSNPsareshared,butsomewillbepopulationspeciﬁc
and relatively rare. The meta-analysis on a single SNP level can naturally only test the overlapping set of common SNPs.
We therefore propose that the SNP-based analysis should be followed by a gene-based analysis.
Gene-based approach
Withthegene-basedapproach,theassociationbetweenatraitandallmarkersintheintragenicandregulatoryregionsofagene
are considered (33). The deﬁnition of gene regulatory regions is still arbitrary, but we propose to deﬁne this as 100 kb upstream
and40 kbdownstreamofagene,assuggestedbyexpressionquantitativetraitlocusanalysis(34).Thereareseveraladvantagesof
the gene-basedapproach over the SNP-basedapproach. Genes are thefunctional units ofthe human genome and causal variants
shouldsomehowinﬂuencegenefunction,eitherbyaffectingtheexpressionorbyaffectingtheresultingprotein.Theidentiﬁcation
ofthecausalgenescanthereforeprovideadirectentrytofunctionalinformation.Secondly,riskvariantsandtheirhaplotypestruc-
turecanvaryacrosspopulations,sothatmeta-analysisandreplicationonasinglevariantlevelcanthusbenotonlyunderpowered,
butalsomisleading.Genefunctionandpathomechanismsare,however,highlyconsistentacrosshumanpopulations.Thirdly,the
gene-based approach can be more powerful than the SNP-based approach because genes (or their functional units) are less
numerous than SNPs, which diminishes the need for multiple testing. Fourthly, the gene-based approach can cope with
population-speciﬁc risk variants, allele frequency differences between populations and haplotype structure differences. It can
alsosuccessfullytackletheproblemofrarevariantspresentwithinasinglepopulation.Althoughtheserarevariantsareindividu-
ally difﬁcult to detect, they can collectively contribute substantially to the genetic risk underlying complex traits (35). The
gene-based analysis for the detection of rare variants should be different from that for detecting common variants. To detect
gene association at the level of common variants, the gene-based P-value should be computed based on the P-value of the indi-
vidualSNPswithinthegene(36).Todetect geneassociationatthelevelofrarevariants,thegene-basedP-valueshouldbecom-
puted by the comparing the collective frequency of rare variants within a gene between cases and controls.
Some possible disadvantages of the gene-based approach are that many associations in GWA studies are to areas without
any genes (gene deserts) or to areas with a large number of genes. Associations to gene deserts are notoriously hard to
interpret and will, to some extent, be detected in the traditional SNP-based part of the proposed analysis framework.
Associations to gene-rich areas will become easier to interpret with a gene-based approach, as for each gene in the area
the association load, and hence the likelihood of each gene being the causal gene, can be calculated.
Pathway-based approach
It has been widely observed that genes associated with complex diseases can converge to the same pathway (37,38). Hence
it follows that the risk genes for a trait, whether they are shared between populations or are speciﬁc to a certain population,
are also expected to converge to common pathways shared between all populations. This convergence to global disease path-
ways means that a pathway-based approach, which simultaneously considers multiple risk genes from different populations,
can aid the interpretation of the associated loci (39). Furthermore, the pathway-based approach has more power to detect risk
variants with a small effect that do not reach the stringent genome-wide signiﬁcance level.
We suggest using a gene-set enrichment analysis which tests the association of modules of functional related genes within
pathways and thus increases the power to detect genes or variants with small effect size (40).
Obviously, the results of each step in this analysis framework will have to be validated in replication studies to prevent the
publication of false-positive results. In addition, the results from each step within the analysis frame-work should be con-
sidered and replicated separately to prevent the magniﬁcation of errors in the initial steps. Since the results of this analysis
framework are likely to give more insight into the mechanisms underlying the traits studied, replication should not be limited
to the genetic level but should be expanded towards functional studies.
Human Molecular Genetics, 2011, Vol. 20, Review Issue 2 R211variants and the tag-SNPs are shared between the different
populations being studied. If the focus of a multi-ethnic
GWA study is to ﬁne-map causal variants within shared risk
loci, the populations need to be genetically close enough to
share such risk loci, but genetically distant enough to have
very heterogeneous LD structures. These two approaches
both assume that risk variants are shared between populations,
whereas our analysis shows that risk variants could be consid-
erably more heterogeneous between populations.
To optimize the power of multi-ethnic GWA studies, we
propose an analysis framework combining SNP-, gene- and
pathway-based analyses, which will deal with the heterogen-
eity between populations by assuming that most population-
speciﬁc risk variants affect risk genes that converge to the
same disease pathways (Box 1 and Fig. 4). We expect this
framework to contribute greatly to the effectiveness of multi-
ethnic GWA studies. The knowledge gained from such studies
will eventually aid advances in clinical intervention and
disease prevention worldwide.
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